These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 8096127)

  • 21. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
    Moritoki H; Hisayama T; Takeuchi S; Miyano H; Kondoh W
    Br J Pharmacol; 1992 Sep; 107(1):196-201. PubMed ID: 1358382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory action of alpha-human atrial natriuretic peptide on noradrenaline-induced synthesis of myo-inositol 1,4,5-trisphosphate in the smooth muscle cells of rabbit aorta.
    Kajikuri J; Kuriyama H
    Br J Pharmacol; 1990 Mar; 99(3):536-40. PubMed ID: 1970498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
    Yu SM; Cheng ZJ; Kuo SC
    Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of inhibition of endothelium-dependent relaxation by halothane, isoflurane, and sevoflurane.
    Nakamura K; Terasako K; Toda H; Miyawaki I; Kakuyama M; Nishiwada M; Hatano Y; Mori K
    Can J Anaesth; 1994 Apr; 41(4):340-6. PubMed ID: 8004742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the soluble guanylyl cyclase activator, YC-1, on vascular tone, cyclic GMP levels and phosphodiesterase activity.
    Galle J; Zabel U; Hübner U; Hatzelmann A; Wagner B; Wanner C; Schmidt HH
    Br J Pharmacol; 1999 May; 127(1):195-203. PubMed ID: 10369473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP.
    Rapoport RM; Murad F
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):281-96. PubMed ID: 6147363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Two types of relaxation responses mediated by cyclic GMP in cerebral arteries].
    Kanamaru K; Waga S; Kojima T; Fujimoto K
    No To Shinkei; 1989 Jun; 41(6):559-65. PubMed ID: 2553081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. H2O2 regulation of vascular function through sGC mRNA stabilization by HuR.
    Martín-Garrido A; González-Ramos M; Griera M; Guijarro B; Cannata-Andia J; Rodriguez-Puyol D; Rodriguez-Puyol M; Saura M
    Arterioscler Thromb Vasc Biol; 2011 Mar; 31(3):567-73. PubMed ID: 21164076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain natriuretic factor. Augmentation of cellular cyclic GMP, activation of particulate guanylate cyclase and receptor binding.
    Song DL; Kohse KP; Murad F
    FEBS Lett; 1988 May; 232(1):125-9. PubMed ID: 2896603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attenuation of endothelium-mediated vasodilation by halothane.
    Muldoon SM; Hart JL; Bowen KA; Freas W
    Anesthesiology; 1988 Jan; 68(1):31-7. PubMed ID: 3257364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presynaptic modulation of sympathetic neurotransmitter release by modulators of cyclic 3',5'-guanosine monophosphate in canine vascular smooth muscle.
    Greenberg SS; Diecke FP; Curro FA; Peevy K; Tanaka TP
    Ann N Y Acad Sci; 1990; 604():305-22. PubMed ID: 1977353
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of nitric oxide-dependent vasodilation by halogenated anesthetics.
    Jing M; Hart JL; Bina S; Muldoon SM
    Adv Pharmacol; 1994; 31():459-69. PubMed ID: 7873431
    [No Abstract]   [Full Text] [Related]  

  • 35. Vasorelaxant mechanism of the new vasodilator, FK409.
    Isono T; Koibuchi Y; Sato N; Furuichi A; Nishii M; Yamamoto T; Mori J; Kohsaka M; Ohtsuka M
    Eur J Pharmacol; 1993 Aug; 246(3):205-12. PubMed ID: 7901040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.
    Winquist RJ; Faison EP; Waldman SA; Schwartz K; Murad F; Rapoport RM
    Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7661-4. PubMed ID: 6150486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Halothane does not protect against vascular injury in isolated cerebral and mesenteric arteries.
    Ogawa K; Tokinaga Y; Iwahashi S; Mizumoto K; Hatano Y
    Can J Anaesth; 2005 Oct; 52(8):870-7. PubMed ID: 16189341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelium-dependent vasodilator-and nitrovasodilator-induced relaxation may be mediated through cyclic GMP formation and cyclic GMP-dependent protein phosphorylation.
    Rapoport RM; Draznin MB; Murad F
    Trans Assoc Am Physicians; 1983; 96():19-30. PubMed ID: 6149646
    [No Abstract]   [Full Text] [Related]  

  • 39. Halothane and isoflurane inhibit vasodilation due to constitutive but not inducible nitric oxide synthase. Implications for the site of anesthetic inhibition of the nitric oxide/guanylyl cyclase signaling pathway.
    Zuo Z; Tichotsky A; Johns RA
    Anesthesiology; 1996 May; 84(5):1156-65. PubMed ID: 8624010
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of vinpocetine (TCV-3B), a vasodilator agent, on cyclic nucleotide metabolism].
    Hagiwara M; Endo T; Hidaka H
    Nihon Yakurigaku Zasshi; 1982 Oct; 80(4):317-23. PubMed ID: 6130034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.